Deficiency of antibacterial peptides in patients with morbus Kostmann: An observation study

Lancet

Volumn 360, Issue 9340, 2002, Pages 1144-1149

  Pütsep, Katrin ^a   Carlsson, Göran ^b   Boman, Hans G ^a   Andersson, Mats ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SUNDERBY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATHELIN; DEFENSIN; DEFENSIN HNP[1-3]; LACTOFERRIN; PEPTIDE DERIVATIVE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MASS SPECTROMETRY; MORBUS KOSTMANN; MUCOSA; NATURAL KILLER CELL; NEUTROPENIA; NEUTROPHIL; PEPTIDE ANALYSIS; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT INFECTION; RESPIRATORY BURST; SALIVA LEVEL; SKIN; TREATMENT OUTCOME; WESTERN BLOTTING;

EID: 0037068959     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11201-3     Document Type: Article

References (29)

1. Kostmann R. Infantile genetic agranulocytosis (agranulocytosis infantilis hereditaria): a new recessive lethal disease in man. Acta Paediatr Scand. 45:1956;1-78.
2. Kostmann R. Infantile genetic agranulocytosis: a review with presentation of ten new cases. Acta Pediatr Scand. 64:1975;362-368.
3. Carlsson G., Fasth A. Infantile genetic agranulocytosis, morbus Kostmann: presentation of six cases from the original "Kostmann family" and a review. Acta Paediatr. 90:2001;757-764.
4. Aprikyan A.A., Dale D.C. Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia. Curr Opin Immunol. 13:2001;535-538.
5. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol. 13:1995;61-92.
6. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 415:2002;389-395.
7. Tossi A. http://www.bbcm.univ.trieste.it/-tossi/pag2.html. (accessed Oct 1, 2002)
8. Huttner K.M., Bevins C.L. Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res. 45:1999;785-794.
9. Borregaard N. Development of neutrophil granule diversity. Ann N Y Acad Sci. 832:1997;62-68.
10. Borregaard N., Cowland J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 89:1997;3503-3521.
11. Sørensen O.E., Follin P., Johnsen A.H., et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood. 97:2001;3951-3959.
12. Lollike K., Kjeldsen L., Sengelov H., Borregaard N. Lysozyme in human neutrophils and plasma: a parameter of myelopoietic activity. Leukemia. 9:1995;159-164.
13. Defraia E., Marinelli A. Oral manifestations of congenital neutropenia or Kostmann syndrome. J Clin Pediatr Dent. 26:2001;99-102.
14. Tanaka D., Miyasaki K.T., Lehrer R.I. Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium. Oral Microbiol Immunol. 15:2000;226-231.
15. Figueredo C., Gustafsson A. Increased amounts of laminin in GCF from untreated patients with periodontitis. J Clin Periodontol. 27:2000;313-318.
16. Sørensen O., Cowland J.B., Askaa J., Borregaard N. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods. 206:1997;53-59.
17. Nagaoka I., Hirata M., Sugimoto K., et al. Evaluation of the expression of human CAP18 gene during neutrophil maturation in the bone marrow. J Leukoc Biol. 64:1998;845-852.
18. Ganz T., Metcalf J.A., Gallin J.I., Boxer L.A., Lehrer R.I. Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest. 82:1988;552-556.
19. Roesler J., Emmendorffer A., Elsner J., Zeidler C., Lohmann-Matthes M., Welte K. In vitro functions of neutrophils induced by treatment with rhG-CSF in severe congenital neutropenia. Eur J Haematol. 46:1991;112-118.
20. Gudmundsson G., Magnusson K., Chowdhary B., Johansson M., Andersson L., Boman H. PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39. Proc Natl Acad Sci USA. 92:1995;7085-7089.
21. Gudmundsson G.H., Agerberth B., Odeberg J., Bergman T., Olsson B., Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem. 238:1996;325-332.
22. Agerberth B., Charo J., Werr J., et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood. 96:2000;3086-3093.
23. Ellwood R., Worthington H.V., Cullinan M.P., Hamlet S., Clerehugh V., Davies R. Prevalence of suspected periodontal pathogens identified using ELISA in adolescents of differing ethnic origins. J Clin Periodontol. 24:1997;141-145.
24. Slots J. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontal disease: introduction. Periodontology. 20:2000;7-13.
25. Dale B.A., Kimball J.R., Krisanaprakornkit S., et al. Localized antimicrobial peptide expression in human gingiva. J Periodontal Res. 36:2001;285-294.
26. Raj P.A., Antonyraj K.J., Karunakaran T. Large-scale synthesis and functional elements for the microbial activity of defensins. Biochem J. 347:2000;633-641.
27. Nagaoka I., Hirota S., Yomogida S., Ohwada A., Hirata M. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res. 49:2000;73-79.
28. Nizet V., Ohtake T., Lauth X., et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature. 414:2001;454-457.
29. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults